ÂÜÀòÂÒÂ×

Dr. Sue Currie serves as Chief Operating Officer of Virion Therapeutics, LLC. She has 20+ years of strategic, operational, and scientific leadership experience in clinical research and development programs, from discovery to post-launch, focusing on cancers and infectious diseases. Before joining Virion, Dr. Currie was Vice President, Head of Medical Affairs, at Nektar Therapeutics. Here, she held global executive and corporate leadership roles within the company and was a core member of the Research and Development senior leadership team. Dr. Currie has biotech organizational leadership experience and has been instrumental in the study design and strategies for clinical programs and the scientific analyses and dissemination of these data in various forums. She has experience developing and building new clinical functions and teams, including medical affairs and other related activities. Before Nektar, Dr. Currie held senior positions at Health Interactions, where she led a team of ~200 people and oversaw all US Operations, as well as at Genentech/Roche in the immuno-oncology arena.

She has authored numerous pivotal scientific publications in immuno-oncology and infectious diseases, including human immunodeficiency virus, hepatitis C virus, and coinfection treatment guidelines. Additionally, she has been a leader in external and internal health educational global and national programs and clinical resources for healthcare providers and other stakeholders in hepatitis and liver diseases and oncology.

Dr. Currie received her BA&S (Hon.) from the University of Saskatchewan, Saskatoon, Canada, her M.A. from the University of Phoenix, Vancouver, Canada, and her Ph.D. from the University of San Francisco. Sue brings a patient-centric focus to her operational and clinical leadership, from her unique experiences, not only within biotechnology, but from her work within the Veterans Health Administration, academic, correctional health, and community care settings.